These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31261289)

  • 1. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
    Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
    Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
    Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
    Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
    Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
    BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
    Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
    Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM).
    Koorstra JB; Maitra A; Morsink FH; Drillenburg P; ten Kate FJ; Hruban RH; Offerhaus JA
    Am J Surg Pathol; 2008 Dec; 32(12):1905-9. PubMed ID: 18813118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the
    Middlebrooks CD; Stacey ML; Li Q; Snyder C; Shaw TG; Richardson-Nelson T; Rendell M; Ferguson C; Silberstein P; Casey MJ; Bailey-Wilson JE; Lynch HT
    Cancer Res; 2019 Jun; 79(11):2992-3000. PubMed ID: 30967399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports.
    van der Wilk BJ; Noordman BJ; Atmodimedjo PN; Dinjens WNM; Laheij RJF; Wagner A; Wijnhoven BPL; van Lanschot JJB
    Eur J Med Genet; 2020 Mar; 63(3):103840. PubMed ID: 31923587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; from p16 to melanoma].
    Gruis NA; Bergman W
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
    Gironi LC; Colombo E; Farinelli P; Giorgione R; Bozzola C; Ogliara P; Pasini B
    Int J Dermatol; 2015 Dec; 54(12):e553-5. PubMed ID: 26381259
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial melanoma; CDKN2A and beyond.
    Gruis NA; van der Velden PA; Bergman W; Frants RR
    J Investig Dermatol Symp Proc; 1999 Sep; 4(1):50-4. PubMed ID: 10537008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
    Lynch HT; Fusaro RM; Lynch JF
    Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
    Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
    Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.
    van der Velden PA; Sandkuijl LA; Bergman W; Hille ET; Frants RR; Gruis NA
    Genome Res; 1999 Jun; 9(6):575-80. PubMed ID: 10400925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome.
    Bottillo I; Valiante M; Menale L; Paiardini A; Papi L; Janson G; Sestini R; Iorio A; De Simone P; Frascione P; Grammatico P
    Dermatol Online J; 2020 Aug; 26(8):. PubMed ID: 32941720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline CDKN2A mutation implicated in predisposition to multiple myeloma.
    Dilworth D; Liu L; Stewart AK; Berenson JR; Lassam N; Hogg D
    Blood; 2000 Mar; 95(5):1869-71. PubMed ID: 10688850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers.
    Ibrahim I; Sibinga Mulder BG; Bonsing B; Morreau H; Farina Sarasqueta A; Inderson A; Luelmo S; Feshtali S; Potjer TP; de Vos Tot Nederveen Cappel W; Wasser M; Vasen HFA
    Eur J Hum Genet; 2018 Aug; 26(8):1227-1229. PubMed ID: 29769629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
    Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
    Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.